Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12506629rdf:typepubmed:Citationlld:pubmed
pubmed-article:12506629lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:12506629lifeskim:mentionsumls-concept:C0023516lld:lifeskim
pubmed-article:12506629lifeskim:mentionsumls-concept:C0011615lld:lifeskim
pubmed-article:12506629lifeskim:mentionsumls-concept:C0021747lld:lifeskim
pubmed-article:12506629lifeskim:mentionsumls-concept:C0038167lld:lifeskim
pubmed-article:12506629lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:12506629lifeskim:mentionsumls-concept:C0033268lld:lifeskim
pubmed-article:12506629lifeskim:mentionsumls-concept:C1521827lld:lifeskim
pubmed-article:12506629lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:12506629lifeskim:mentionsumls-concept:C1998793lld:lifeskim
pubmed-article:12506629pubmed:issue6lld:pubmed
pubmed-article:12506629pubmed:dateCreated2002-12-31lld:pubmed
pubmed-article:12506629pubmed:abstractTextThe impact of purified staphylococcal toxoid (PST) on the in vitro production of interferon (IFN) by blood leukocytes was evaluated. PST was found to produce a stimulating effect on the production of alpha-IFN in patients with atopic dermatitis (AD): in 88% of cases a two-fivefold increase in IFN production was observed in AD patients in comparison with healthy donors. In addition, the incubation of leukocytes obtained from atopic and nonatopic patients with PST was shown to stimulate the production of gamma-IFN by these leukocytes fivefold, on the average. These results give theoretical basis for use of PST (as an inducer of endogenic IFN) for AD patients treatment.lld:pubmed
pubmed-article:12506629pubmed:languageruslld:pubmed
pubmed-article:12506629pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12506629pubmed:citationSubsetIMlld:pubmed
pubmed-article:12506629pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12506629pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12506629pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12506629pubmed:statusMEDLINElld:pubmed
pubmed-article:12506629pubmed:issn0372-9311lld:pubmed
pubmed-article:12506629pubmed:authorpubmed-author:GrigorianS...lld:pubmed
pubmed-article:12506629pubmed:authorpubmed-author:MokronosovaM...lld:pubmed
pubmed-article:12506629pubmed:authorpubmed-author:Ospel'nikovaT...lld:pubmed
pubmed-article:12506629pubmed:authorpubmed-author:LiaporovaT...lld:pubmed
pubmed-article:12506629pubmed:authorpubmed-author:RuzovaE AEAlld:pubmed
pubmed-article:12506629pubmed:issnTypePrintlld:pubmed
pubmed-article:12506629pubmed:ownerNLMlld:pubmed
pubmed-article:12506629pubmed:authorsCompleteYlld:pubmed
pubmed-article:12506629pubmed:pagination52-5lld:pubmed
pubmed-article:12506629pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:12506629pubmed:meshHeadingpubmed-meshheading:12506629...lld:pubmed
pubmed-article:12506629pubmed:meshHeadingpubmed-meshheading:12506629...lld:pubmed
pubmed-article:12506629pubmed:meshHeadingpubmed-meshheading:12506629...lld:pubmed
pubmed-article:12506629pubmed:meshHeadingpubmed-meshheading:12506629...lld:pubmed
pubmed-article:12506629pubmed:meshHeadingpubmed-meshheading:12506629...lld:pubmed
pubmed-article:12506629pubmed:meshHeadingpubmed-meshheading:12506629...lld:pubmed
pubmed-article:12506629pubmed:meshHeadingpubmed-meshheading:12506629...lld:pubmed
pubmed-article:12506629pubmed:meshHeadingpubmed-meshheading:12506629...lld:pubmed
pubmed-article:12506629pubmed:articleTitle[Effect of purified staphylococcal toxoid preparation on the in vitro production of interferon by leukocytes from patients with atopic dermatitis].lld:pubmed
pubmed-article:12506629pubmed:affiliationMechnikov Research Institute for Vaccines and Sera, Gamaleya Research Institute of Epidemiology and Microbiology, Moscow, Russia.lld:pubmed
pubmed-article:12506629pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12506629pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:12506629pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:12506629pubmed:publicationTypeEnglish Abstractlld:pubmed